← Leaderboards
Ryan K. Bachtell
Oregon Health And Science University
$3,283,886
Attributed
$5,048,913
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $687.6K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,048,913 · 6
By mechanism
U01$2,329,915 · 1
R01$1,944,496 · 1
R21$423,500 · 1
R03$151,500 · 1
F32$141,700 · 1
F31$57,802 · 1
Top collaborators
- Marissa A Ehringer6 shared
- Laura Maren Saba6 shared
- Michael Saddoris2 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Abraham A Palmer$32,542,324
- Suzanne H Mitchell$5,481,552
- Rae Nishi$10,112,269
- Sue A Aicher$13,483,140
- Clare J Wilhelm$117,343
Others in their field
Top investigators on “Nucleus Accumbens”
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$48,768,834
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$23,420,464
- Peter W Kalivas · Ralph H Johnson Va Medical Center$21,520,620
- Marina Elizabeth Wolf · Oregon Health & Science University$19,421,692
- Scott J Russo · Icahn School Of Medicine At Mount Sinai$17,205,046
- Mary Kay Lobo · University Of Maryland Baltimore$15,138,110
Research focus
Nucleus AccumbensSelf AdministrationBehaviorPharmaceutical PreparationsBrainBehavioralRattusAddictionIntakeNeuronsNeurobiologyPathway InteractionsDrug AddictionCocaineDopamine ReceptorAdenosine A1 ReceptorGtp-Binding ProteinsDopamineAdenosineDrug UsageChronicAffectBehavior ControlDrug Relapse
Grant awards (21)
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$391,137
U01 · FY2024 · DA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$476,736
U01 · FY2023 · DA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$476,736
U01 · FY2022 · DA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$473,937
U01 · FY2021 · DA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$16,287
U01 · FY2021 · DA
Identification of genes and genetic networks contributing to opioid use disorder traits in the Hybrid Rat Diversity Panel$495,082
U01 · FY2020 · DA
Monitoring real-time adenosine release in the NAc with fast-scan cyclic voltammetry$192,500
R21 · FY2020 · DA
Monitoring real-time adenosine release in the NAc with fast-scan cyclic voltammetry$231,000
R21 · FY2019 · DA
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$338,472
R01 · FY2017 · DA · contact PI
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$372,831
R01 · FY2016 · DA · contact PI
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$441,874
R01 · FY2015 · DA · contact PI
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$338,472
R01 · FY2014 · DA · contact PI
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$114,375
R01 · FY2014 · DA · contact PI
Adenosine Receptor Involvement in Methamphetamine Reward and Relapse$338,472
R01 · FY2013 · DA · contact PI
Effects of Adenosine Signaling on Cocaine Reward and Relapse$75,750
R03 · FY2012 · DA · contact PI
Effects of Adenosine Signaling on Cocaine Reward and Relapse$75,750
R03 · FY2011 · DA · contact PI
Dopamine receptor interactions with GluR1 in addiction$50,428
F32 · FY2006 · DA · contact PI
Dopamine receptor interactions with GluR1 in addiction$48,296
F32 · FY2005 · DA
Dopamine receptor interactions with GluR1 in addiction$42,976
F32 · FY2004 · DA
Characterizing the Edinger-Westphal response to alcohol$29,854
F31 · FY2002 · AA
Characterizing the Edinger-Westphal response to alcohol$27,948
F31 · FY2001 · AA